HBS
ROIV icon

Howard Bailey Securities’s Roivant Sciences ROIV Stock Holding History

Howard Bailey Securities’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,373
Closed -$128K – 160
2025
Q2 		$128K Buy
11,373
+191
+2% +$2.07K 0.04% 149
2025
Q1 		$113K Sell
11,182
-23
-0.2% -$249 0.04% 154
2024
Q4 		$133K Sell
11,205
-521
-4% -$6.16K 0.05% 165
2024
Q3 		$135K Buy
+11,726
New +$134K 0.05% 164

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return

Howard Bailey Securities's ROIV Position: Q3 2025 in Review

Howard Bailey Securities sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 11,373 shares — an estimated $128K sold.

Howard Bailey Securities first reported a position in ROIV in Q3 2024 and held it in 4 quarters. The position peaked at $135K in Q3 2024. 338 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Howard Bailey Securities reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Howard Bailey Securities sold 11,373 Roivant Sciences shares in Q3 2025, an estimated $128K.
  • Howard Bailey Securities first reported a position in Roivant Sciences in Q3 2024 and held it in 4 quarters.
  • Howard Bailey Securities's Roivant Sciences position peaked at $135K in Q3 2024.
  • 338 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Howard Bailey Securities's 13F filing for Q3 2025, filed 4 Nov 2025.